Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
neuroscience
Pharma
Neurocrine elevates BD chief to succeed founder and CEO
The paucity of commercial-stage neuroscience biotechs has made Neurocrine a regular name on M&A watch lists. Now, the firm has a new CEO.
Angus Liu
May 29, 2024 11:42am
JPM24: Alkermes ready to roll as pure-play neuroscience company
Jan 10, 2024 9:04am
Biogen's Alzheimer's sales are negative early in Leqembi launch
Apr 25, 2023 11:40am
Genentech exec sheds more light on plans for biologics plant
Feb 21, 2023 9:50am
Novartis leader departs for Boehringer CMO spot
Nov 4, 2022 2:35pm
Pfizer buys Biohaven for $11.6B in grand return to neuroscience
May 10, 2022 10:15am
